Molecular basis of resistance to cytochromebc1inhibitors
Open Access
- 1 March 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in FEMS Yeast Research
- Vol. 8 (2), 183-192
- https://doi.org/10.1111/j.1567-1364.2007.00328.x
Abstract
Inhibitors of the mitochondrial respiratory chain enzyme cytochrome bc1 (respiratory complex III) have been developed as antimicrobial agents. They are used in agriculture to control plant pathogenic fungi and in medicine against human pathogens, such as the malaria parasite Plasmodium falciparum, or Pneumocystis jiroveci (an opportunistic pathogenic fungus life-threatening in immuno-compromised patients). These respiratory inhibitors are thus effective against a broad range of important pathogens. Unfortunately, the problem of acquired resistance has rapidly emerged. A growing number of pathogen isolates resistant to inhibitor treatment have been reported, and this resistance is often linked to mutation within cytochrome b, one of the essential catalytic subunits of the complex. Saccharomyces cerevisiae is an invaluable model in order to assess the impact of the mutations on the sensitivity to the drugs, on the respiratory capacity and the fitness of cells. In this minireview, the inhibitors, their mode of action, and the mutations implicated in resistance and studied in yeast are briefly reviewed. Four mutations that are of particular importance in medicine and in agriculture are briefly reviewed and described in more detail and the molecular basis of resistance and of evolution of the mutations is discussed succinctly.Keywords
This publication has 30 references indexed in Scilit:
- Molecular basis of Toxoplasma gondii atovaquone resistance modeled in Saccharomyces cerevisiaeMolecular and Biochemical Parasitology, 2006
- Fixing the Q cycleTrends in Biochemical Sciences, 2005
- The quinone chemistry of bc complexesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2004
- Crystallographic Studies of Quinol Oxidation Site Inhibitors: A Modified Classification of Inhibitors for the Cytochrome bc 1 ComplexJournal of Molecular Biology, 2004
- Modeling the Qo site of crop pathogens in Saccharomyces cerevisiae cytochrome bEuropean Journal of Biochemistry, 2004
- Human Disease-related Mutations in Cytochrome b Studied in YeastPublished by Elsevier BV ,2004
- Recapitulation in Saccharomyces cerevisiae of Cytochrome b Mutations Conferring Resistance to Atovaquone in Pneumocystis jiroveciAntimicrobial Agents and Chemotherapy, 2003
- Mechanisms influencing the evolution of resistance to Qo inhibitor fungicidesPest Management Science, 2002
- Mechanism of Ubiquinol Oxidation by the bc1 Complex: Different Domains of the Quinol Binding Pocket and Their Role in the Mechanism and Binding of InhibitorsBiochemistry, 1999
- The protonmotive Q cycle: A general formulationFEBS Letters, 1975